Center for Systems Biology, Massachusetts General Hospital, Boston 02114, USA.
Cancer Res. 2012 Jun 15;72(12):2949-56. doi: 10.1158/0008-5472.CAN-11-4096. Epub 2012 Apr 13.
Observing drug responses in the tumor microenvironment in vivo can be technically challenging. As a result, cellular responses to molecularly targeted cancer drugs are often studied in cell culture, which does not accurately represent the behavior of cancer cells growing in vivo. Using high-resolution microscopy and fluorescently labeled genetic reporters for apoptosis, we developed an approach to visualize drug-induced cell death at single-cell resolution in vivo. Stable expression of the mitochondrial intermembrane protein IMS-RP was established in human breast and pancreatic cancer cells. Image analysis was then used to quantify release of IMS-RP into the cytoplasm upon apoptosis and irreversible mitochondrial permeabilization. Both breast and pancreatic cancer cells showed higher basal apoptotic rates in vivo than in culture. To study drug-induced apoptosis, we exposed tumor cells to navitoclax (ABT-263), an inhibitor of Bcl-2, Bcl-xL, and Bcl-w, both in vitro and in vivo. Although the tumors responded to Bcl-2 inhibition in vivo, inducing apoptosis in around 20% of cancer cells, the observed response was much higher in cell culture. Together, our findings show an imaging technique that can be used to directly visualize cell death within the tumor microenvironment in response to drug treatment.
在体内观察肿瘤微环境中的药物反应在技术上具有挑战性。因此,通常在细胞培养中研究细胞对分子靶向抗癌药物的反应,而这并不能准确反映体内生长的癌细胞的行为。我们使用高分辨率显微镜和荧光标记的凋亡遗传报告基因,开发了一种在体内以单细胞分辨率可视化药物诱导细胞死亡的方法。在人乳腺癌和胰腺癌细胞中稳定表达线粒体膜间蛋白 IMS-RP。然后使用图像分析来定量测定凋亡和不可逆的线粒体通透时 IMS-RP 向细胞质中的释放。与培养物相比,体内的乳腺癌和胰腺癌细胞具有更高的基础凋亡率。为了研究药物诱导的凋亡,我们将肿瘤细胞暴露于 navitoclax(ABT-263)中,navitoclax 是 Bcl-2、Bcl-xL 和 Bcl-w 的抑制剂,无论是在体外还是体内。尽管肿瘤对体内的 Bcl-2 抑制有反应,诱导大约 20%的癌细胞凋亡,但在细胞培养中观察到的反应要高得多。总之,我们的研究结果表明了一种成像技术,可用于直接观察肿瘤微环境中对药物治疗的反应的细胞死亡。